Aernoud Fiolet

157 Colchicine in Patients with Chronic Coronary Disease Table S8 On-Treatment Analysis for Adverse Events Colchicine (N = 2740) Placebo (N = 2738) Hazard Ratio (95% CI) no. (%) rate /100 person -yr no. (%) rate /100 person -yr Noncardiovascular death 28 (1.0%) 0.4 15 (0.5%) 0.2 1.86 (0.99-3.48) Diagnosis of cancer 107 (3.9%) 1.5 104 (3.8%) 1.5 1.03 (0.78-1.34) Hospitalization for infection 124 (4.5%) 1.8 138 (5.0%) 2.0 0.89 (0.70-1.14) Hospitalization for pneumonia 42 (1.5%) 0.6 53 (1.9%) 0.7 0.79 (0.53-1.18) Hospitalization for gastro- intestinal reason 48 (1.8%) 0.7 43 (1.6%) 0.6 1.11 (0.74-1.68) Neutropenia 3 2 Myotoxicity 3 3